A summary of selected literature articles related to dietary supplements from the NIH PubMed database that might be of interest to CHPA member companies.
Herein CHPA provides feedback on FDA’s recent draft guidance document addressing the labeling of dietary supplements containing live microbials (also referred to as probiotics).
CHPA submitted comments this week to the Food and Drug Administration regarding the proposed development of an authorized list of dietary ingredients marketed prior to the Dietary Supplement Health and Education Act.
This document was developed by members of the CHPA Dietary Supplements Committee Probiotics Labeling Group to provide voluntary guidelines for use by manufacturers of dietary supplement products containing probiotic ingredients.
Regulation of Dietary Supplements covers marketing, manufacturing, labeling, and advertising enforced by FDA and the Federal Trade Commission. See these FAQs to learn more.
Explore our list of resources to learn more about the dietary supplement category and how it is regulated by the U.S. Food and Drug Administration and Federal Trade Commission.
